Novel Fluorine-Containing NMDA Antagonists for Brain Imaging: In Vitro Evaluation
The NMDA receptor has been implicated in neuronal death following stroke, brain injury and neurodegenerative disorders (e.g. Alzheimer's, Parkinson's and Huntington's disease) and in physiological functions (e.g. memory and cognition). Non-competitive antagonists, such as MK- 801 and CNS-1102, that block the action of glutamate at the NMDA receptor have been shown to be neuroprotective by blocking the influx of calcium into the cells. As a result, they are being considered as therapeutic agents for the above mentioned diseases. Several Fluorine-containing novel analogs of NMDA channel blockers have been synthesized and evaluated in search of a compound suitable for 18F labeling and Positron Emission Tomography (PET). Based on in vitro binding assay studies on rat brain membranes, the novel compounds examined displayed a range of affinities. Preliminary analyses indicated that chlorine is the best halogen on the ring, and that ethyl fluoro derivatives are more potent than methyl-fluoro compounds. Further analysis based on autoradiography will be needed to examine the regional binding characteristics of the novel compounds examined in this study. Labeling with 18F will allow the use of these compounds in humans, generating new insights into mechanisms and treatment of diseases involving malfunction of the glutamatergic system in the brain.
- Research Organization:
- DOESC (USDOE Office of Science (SC) (United States))
- Sponsoring Organization:
- USDOE Office of Science (SC)
- OSTI ID:
- 1051241
- Journal Information:
- Journal of Undergraduate Research, Vol. 1
- Country of Publication:
- United States
- Language:
- English
Similar Records
Modulation of the NMDA receptor by polyamines
Mechanism of NMDA receptor channel block by MK-801 and memantine